Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
14,033,333
-
Total 13F shares
-
10,108,915
-
Share change
-
+1,265,485
-
Total reported value
-
$415,390,325
-
Put/Call ratio
-
139%
-
Price per share
-
$41.10
-
Number of holders
-
151
-
Value change
-
+$53,509,061
-
Number of buys
-
80
-
Number of sells
-
71
Institutional Holders of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) as of Q1 2014
As of 31 Mar 2014,
Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) was held by
151 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,108,915 shares.
The largest 10 holders included
DIMENSIONAL FUND ADVISORS LP, BlackRock Fund Advisors, SYSTEMATIC FINANCIAL MANAGEMENT LP, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Allianz Asset Management AG, WELLINGTON MANAGEMENT CO LLP, BOGLE INVESTMENT MANAGEMENT L P /DE/, and State Street Corp.
This page lists
151
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.